“It’s an alarming trend,” says Skyler Johnson, MD. “Some patients choose to forego or delay cancer treatments that have been proven to prolong life and/or cure their cancer, in favor of unproven therapies.”
- June 28, 2019
Smilow Welcomes Two New Radiation Oncologists to Greenwich Hospital
- June 17, 2019
The Amgen Scholars Program at Yale is a partnership between the Amgen Foundation and the Yale School of Medicine MD-PhD and Biological and Biomedical Sciences PhD programs. The goal of the program is to recruit students from under-represented groups to biomedical careers and help them succeed as scientists or physican-scientists.
- June 14, 2019
Connecticut Magazine’s 2019 “Best Doctors” list includes 217 Yale Medicine physicians in 50 specialties who were selected by their peers as the best in their fields.
- June 05, 2019
James B. Yu, MD, associate professor, therapeutic oncology, director, Prostate and Genitourinary Cancer Radiotherapy Program, Yale Cancer Center, discusses drawbacks of radiation therapy in prostate cancer.
- June 03, 2019
Connecticut Magazine has named 72 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2019 Best Doctors guide. Published in the magazine’s June issue, the Best Doctors list consists of 782 Connecticut physicians from 78 medical specialties.
- May 17, 2019
AstraZeneca’s experimental cancer drug cediranib was originally developed to inhibit VEGF, a protein that prompts the growth of the blood vessels tumors need to survive. But in clinical trials it hasn’t proven to be all that effective, failing to stack up to Roche’s anti-VEGF blockbuster Avastin.
- May 15, 2019
Yale Cancer Center researchers have found that a cancer drug thought to be of limited use possesses an unforeseen property. It is able to stop certain cancer cells from repairing their DNA in order to survive. The study suggests that combining this drug, cediranib, with other agents could potentially deliver a lethal blow in cancer that uses a specific process to create DNA repair cells.
- April 19, 2019
Yale New Haven Children's Hospital has opened the Lauren Telesz/Smilow Teen Center, to fill an important gap between pediatric and adult cancer care. The center dovetails with a larger goal to help improve survival rates for adolescents and young adults with cancer.
- March 28, 2019
Smilow Cancer Hospital’s Greenwich Hospital Campus announces appointment of Bruce McGibbon, MD, to lead radiation oncology
Bruce McGibbon, MD, will join the Smilow Cancer Hospital’s Greenwich Hospital Campus as the new medical director of Radiation Oncology effective in July.